RedHill Biopharma Ltd. (RDHL)
2.79
0.04 (1.45%)
At close: Mar 28, 2025, 3:56 PM
2.70
-3.23%
After-hours: Mar 28, 2025, 07:58 PM EDT
RedHill Biopharma Ltd. Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | 23.92M | -71.67M | -97.74M | -76.17M | -42.3M | -38.82M | -45.54M | -29.37M | -21.09M | -10.71M | -10.63M | -10.33M | -15.5M | -2.54M |
| Depreciation & Amortization | 1.99M | 8.15M | 18.15M | 8.74M | 1.21M | 90K | 81K | 44K | 36K | 27K | 24K | 24K | 15K | n/a |
| Stock-Based Compensation | 1.65M | 5.67M | 10.21M | 4.2M | 3.03M | 2.68M | 2.23M | 1.68M | 1.36M | 1.75M | 1.25M | 1.65M | 2.86M | 80K |
| Other Working Capital | -50.44M | 14.49M | 10.04M | 33.13M | -1.83M | 2.45M | 1M | 711K | 702K | -2.59M | -290K | -109K | n/a | n/a |
| Other Non-Cash Items | -47.79M | 20.65M | 5.37M | 6.03M | -347K | 35K | -123K | 94K | -69K | 50K | -70K | 1.47M | 8.11M | 853K |
| Deferred Income Tax | n/a | n/a | 123K | 195K | n/a | 136K | -5.08M | -1.26M | -638K | 8K | -64K | -73K | -602K | n/a |
| Change in Working Capital | -15.58M | 8.01M | -1.15M | 8.42M | -2.34M | 1.42M | 3.66M | 553K | 2.57M | -3.36M | 1.05M | 459K | 430K | -21K |
| Operating Cash Flow | -35.82M | -29.18M | -65.05M | -48.58M | -40.75M | -34.46M | -44.77M | -28.26M | -17.83M | -12.23M | -8.44M | -6.79M | -4.69M | -1.63M |
| Capital Expenditures | -11K | -198K | -115K | -53.77M | -203K | -58K | -1.18M | -120K | -1.63M | -1.1M | -224K | -108K | -181K | -1.11M |
| Acquisitions | n/a | n/a | 8.03M | n/a | 35K | 35K | 11.96M | -36.87M | 17.94M | 15.96M | n/a | 100K | n/a | n/a |
| Purchase of Investments | n/a | n/a | -8.5M | n/a | -4.33M | -6.98M | -34.92M | -12.25M | -29.56M | -17M | n/a | -1.03M | -4.59M | n/a |
| Sales Maturities Of Investments | 14.96K | 8.5M | 475K | 18.13M | 9.69M | 12.39M | 17.52M | 36.84M | 10M | 243K | 1.35M | 4.12M | n/a | 92K |
| Other Investing Acitivies | 10.00 | 8.5M | -8.03M | -35.24M | -35K | -35K | -11.96M | 36.87M | -17.94M | -15.96M | 1.14M | -100K | n/a | n/a |
| Investing Cash Flow | 4K | 8.3M | -8.14M | -35.65M | 5.16M | 5.35M | -18.58M | 24.47M | -21.19M | -17.86M | 1.13M | 2.98M | -4.77M | -1.02M |
| Debt Repayment | n/a | -1.48M | -1.68M | 76.45M | -796K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.09M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 7.48M | -10.88M | -3.39M | -15.95M | 5K | -139K | 3.44M | 263K | 108K | 5M | 2.18M | 302K | 1.18M | n/a |
| Financial Cash Flow | 21.44M | 11.45M | 73.46M | 84.37M | 35.51M | 41.76M | 25.65M | 36.02M | 54.79M | 24.37M | 2.28M | 6.55M | 13.84M | 11.09M |
| Net Cash Flow | -14.4M | -9.51M | 179K | 272K | 18K | 12.55M | -37.33M | 32.27M | 15.62M | -5.96M | -4.96M | 2.74M | 5.02M | 8.45M |
| Free Cash Flow | -35.83M | -29.38M | -65.16M | -102.35M | -40.95M | -34.52M | -45.95M | -28.38M | -19.46M | -13.33M | -8.66M | -6.9M | -4.87M | -2.74M |